Intravenous immune globulin (IVIG) is indicated for IgG replacement in antibody deficiency syndromes and as immunoregulatory therapy in some autoimmune diseases. Two case histories illustrate both aspects of IVIG therapy. 1. Patient 1 is a 24-year-old male with agammaglobulinemia. He was successively treated with monthly IMIG, paternal plasma, and then over the last 5 years, IVIG. On IgG doses of 250 mg/kg q/4 weeks, IgG trough levels remained below 200 mg IgG/dl. IgG half-life was reduced. Although asymptomatic for prolonged periods of time, he eventually developed clinically evident inflammatory bowel disease. Optimal IVIG replacement therapy requires normal IgG half-life and adequate IgG trough levels. 2. Patient 2 is a 12-year-old girl with autoimmune neutropenia, recurrent skin infections, and ileitis unresponsive to antibiotics and to steroid therapy. IVIG at a dose of 3,000 mg/IgG/kg over 3 days significantly increased her neutrophil count. Subsequently, she has required 1,000 mg/kg of IVIG q/4 weeks for maintenance. Antineutrophil autoantibodies have persisted. There is synergism of IVIG with high doses of corticosteroids. The mechanism of action of IVIG seems to involve a blockage of the RES system. IVIG therapy is safe even at high doses for most patients. However, anaphylactic reactions have been observed in IgA-deficient patients with IgE anti-IgA antibodies. The full spectrum of therapeutic applications of IVIG is still being explored. For some patients self-infusion of IVIG at home is an appealing treatment alternative.
IVIG has been used to treat AIN, but it is not always effective. We report a patient in which the concommitant use of IVIG and steroid was more effective than either alone. A 10 year old girl with neutropenia and anti-neutrophil antibodies had chronic gingivitis, buccal erosions, and staphylocca skinabsces-4 ses. Absolute neutrophil counts (ANC) were 40-400/mm . IVIG at 2 gmlkg had no effect. She later developed fever, anorexia, and abdominal pain due to bacterial ileitis. Antibiotics alone gaveonly partial clinical improvement. The addition of Solumedrol, lmglkgl day, transiently raised the ANC from 100 to 3500. The ANC subsequently declined to
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.